ArticleCancer discovery2022
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Chewei Anderson Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
81 papers cite itlatest 60 shown
this paperpooled itcites it